CytoSorbents CFO Buys Shares, Signals Confidence Amid Volatility
CytoSorbents CFO’s recent $0.44 share purchase signals confidence in a volatile biotech stock, offering insight for investors eyeing its blood‑purification tech.
3 minutes to read
CYTOSORBENTS CORP